Phosphagenics’ pharmaceutical division is focused on enhancing the delivery of proven pharmaceuticals utilising Phosphagenics' TPM® delivery technology.
To maximise return on the Company’s R&D investment, Phosphagenics’ strategy is to partner with larger pharmaceutical companies, capitalising on their development capabilities, at the appropriate stage in product development.
The objective of any partnering agreement is to generate revenues from three sources:
- milestone payments and development fees during the pre-marketing phases of product development;
- royalties on product sales by partners; and
- manufacturing and supply of TPM® to partners.
Phosphagenics' choice of development products is based on the market opportunity and overall commercial viability of each individual product candidate.